Press brief presented by Terry J. Fry, MD of Center for Cancer Research, Bethesda, MD, on MRD negative complete remissions following anti-CD22 CAR in children and young adults with relapsed/refractory ALL. Recorded at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest Hemonc news and updates